The Welfare Committee approved a budget of 1.7 billion won. Payment can be made next year if the plenary session is passed. The budget for relieving abnormal cases and side effects of drugs being administered in Korea through the EUA system, which is not approved based on the current Pharmaceutical Act, is smoothly being secured. This is because the National Assembly's Health and Welfare Committee recently voted 1.79 billion won for next year's budget to relieve damage to EUA drugs such as COVID-19 treatments, and attention is focused on the results of the special committee on budget settlement. Given that the EUA drug damage relief budget is recognized by multiple lawmakers and professional committee members of the W